The phase of clinical trials in humans with the corona vaccine developed at the Institute for Biological Research in Israel is starting today.
The experiments will be conducted at Hadassah Ein Kerem Hospital in Jerusalem and Sheba Hospital in Tel Hashomer. Segev Harel, 26, from Sde Nehemia, is the first Israeli to participate today in an experiment to be held in Tel Hashomer.
“I decided to volunteer for the experiment for some very simple reasons,” Harel said. “First I see a great privilege in helping and contributing. A lot of people have been hurt by the corona both health, mentally and especially financially – and if that’s the small contribution I could make, participate in this thing and bring hope – that we’re on the way to ending the plague then I did mine,” he said.
“I have no real worries. I am a healthy guy and I believe in my body’s immune system. I sat with the doctors who run the experiment and think everything will be fine. I’m even sure of that,” he said. “My immediate family is happy and supported that I have the opportunity to do this historic thing.”
“As with anything in life that has a risk, there are those who are more supportive and there are those who are less, but I respect everyone. In the end it is my decision and the more I delve into the issue I am even more whole with it.”
At the same time, the experiment is also taking place at Hadassah Medical Center. Hadassah Hospital announced yesterday that the first participant to receive the vaccine at the hospital is a 34-year-old young man. This is a doctoral student from the south of the country, who volunteered to take part in the experiment.
Last night, the first participant received a message from the director of the clinical research unit at Hadassah, Prof. Yossi Karko, and from the research coordinator, Hannah Drori, that he was found suitable to participate in the trial, and the final details were agreed with him.
The Israeli vaccine developed at the Biological Institute uses a similar technology that has been successfully tested for some time against the Ebola virus. In the first phase of the trial the vaccine will be injected for 18-55 year olds, then for 56-85 year olds.
These were the details of the news The trial of the Israeli vaccine for Corona is underway –... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at news1.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.